Erschienen in:
01.10.2015 | Therapy in Practice
Management of Hematologic Malignancies: Special Considerations in Pregnant Women
verfasst von:
Odelia Amit, Merav Barzilai, Irit Avivi
Erschienen in:
Drugs
|
Ausgabe 15/2015
Einloggen, um Zugang zu erhalten
Abstract
The diagnosis and management of hematologic malignancy during pregnancy is a significant challenge. This is due to both medical and ethical considerations regarding when and how to treat this special sub-group of patients. Recurring uncertainties remain around appropriate imaging techniques, timing and dosage of chemotherapy, and timing of delivery. In this article we examine and summarize current literature in this field to assist physicians in their understanding and management of this patient group. Special attention has been given to diagnostic and staging procedures, risks associated with chemotherapy at different stages of gestation, and chemotherapy-dose adaption during pregnancy. In addition, recommended guidelines for management of lymphoma, leukemia, and planning delivery are discussed. A multidisciplinary team approach is critical for patient care, as is shared decision making with the patient and family.